2nd Annual Gene Therapy for Rare Disorders Europe on October 23-24, 2018 in London, UK and will give two oral presentations.
GenSight will attend the Oral presentation: Supporting Clinical Development in the Gene Therapy Space Through Biodistribution & Immunogenicity Assessment
- Oral presenter: Céline Bouquet, Preclinical Manager
- Date & Time: Tuesday 23 October, 12.00 – 12.30 PM
- Topic Title: Defining & Executing Robust Clincal Development Strategies
Oral presentation: Managing Late-Stage Gene Therapy Development in Preparation for MA/BLA Applications
- Oral presenter: Isabelle Pengué Koyi, VP, Regulatory Affairs & Quality
- Date & Time: Wednesday 24 October, 3.45-4.15 PM
- Topic Title: Navigating the Complex European Regulatory Landscape